Attached files
| file | filename |
|---|---|
| 10-Q/A - SensiVida Medical Technologies, Inc. | v211702_10qa.htm |
| EX-31.1 - SensiVida Medical Technologies, Inc. | v211702_ex31-1.htm |
| EX-31.2 - SensiVida Medical Technologies, Inc. | v211702_ex31-2.htm |
| EX-10.3 - SensiVida Medical Technologies, Inc. | v211702_ex10-3.htm |
EXHIBIT
32
CERTIFICATION
OF THE PRESIDENT AND
THE
CHIEF FINANCIAL OFFICER PURSUANT TO
18
U.S.C. SECTION 1350
In
connection with the Quarterly Report of Mediscience Technology Corp., (the
“Company”) on Form 10-Q/A for the quarter ended November 30, 2009 as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Jose Mir, and I, Frank D. Benick, certify, that, to my knowledge:
|
(1)
|
The
Report fully complies with the requirements of Section 13 (a) of 15 (d) of
the Securities Exchange Act of 1934 (15 U.S.C. §78o(d));
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
/s/
Jose Mir
|
||
|
February
16, 2011
|
||
|
Jose
Mir
|
||
|
President
|
||
|
/s/
Frank D. Benick
|
||
|
February
16, 2011
|
||
|
Frank
D. Benick
|
||
|
Chief
Financial Officer
|
The
foregoing certification is being furnished in accordance with Securities and
Exchange Commission Release Nos. 34-47551 and 34-47986 and shall not be
considered “filed” as part of this 10-Q/A.
This
certification is made solely for purposes of 18 U.S.C. Section 1350, subject to
the knowledge standard contained therein, and not for any other
purpose.